Please assess the completion status of the following clinical trial:

Trial Title: Controlled-Release Oxycodone Versus Naproxen at Home After Ambulatory Surgery: A Randomized Controlled Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Patients scheduled for painful ambulatory surgery (knee arthroscopy, unilateral open or laparoscopic inguinal hernia repair)~* American Society of Anesthesiologists (ASA) physical classification I or II~Exclusion Criteria:~* cognitive impairment,~* preoperative pharmacologic pain treatment~* allergy to or a contraindication for taking the study medication (e.g. paracetamol, oxycodone, naproxen or another NSAID)~* porphyria~* pregnancy or lactation~* history of severe renal, hepatic, pulmonary, or cardiac failure~* current symptoms or history of gastrointestinal bleeding, ileus or chronic obstipation~* history of substance abuse, or use of medication with a suppressive effect on the central nervous system

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- PCM/NAPR group (Type: NO_INTERVENTION): paracetamol 1000 mg orally four times a day for 48 hours postoperatively and naproxen 500 mg orally twice a day for 48 hours postoperatively (standard hospital pain protocol for treatment of acute postoperative pain at home after painful day-case surgery)
- PCM/Oxy1 group (Type: ACTIVE_COMPARATOR): Controlled Release oxycodone 10 mg orally twice a day for 24 hours and paracetamol 1000 mg orally four times a day for 48 hours postoperatively
- PCM/Oxy2 group (Type: ACTIVE_COMPARATOR): CR oxycodone 10 mg orally twice a day for 48 hours and paracetamol 1000 mg orally four times a day for 48 hours postoperatively

Based on this trial design, predict the completion outcome and termination type (if applicable).